Suchergebnisse - Dexamethasone OR corticosteroid

PubPharm (42)

1

Infections in relapsed myeloma patients treated with isatuximab plus pomalidomide and dexamethasone during the COVID-19 pandemic : Initial results of a UK-wide real-world study

enthalten in: Hematology (Amsterdam, Netherlands) | 2022

von Djebbari, F. | Rampotas, A. | Vallance, G. | +26

2

Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK

enthalten in: Clinical and experimental immunology | 2022

von Shields, A. | Anantharachagan, A. | Arumugakani, G. | +59

3

Emerging Therapies for COVID-19 : The Value of Information From More Clinical Trials

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2022

von Dijk, S. | Krijkamp, E. | Kunst, N. | +3

4

The utility of CRP with the use of dexamethasone and Tocilizumab in critically ill patients with COVID-19

enthalten in: Journal of critical care | 2022

von Zacharias, H. | Mungara, R. | Wilson, A. | +2

5

Blood exchange transfusion with dexamethasone and Tocilizumab for management of hospitalized patients with sickle cell disease and severe COVID-19 : Preliminary evaluation of a novel algorithm

enthalten in: American journal of hematology | 2022

von De Luna, G. | Habibi, A. | Odièvre, M. | +14

6

Comparing the efficacy of tocilizumab with corticosteroid therapy in treating COVID-19 patients : a systematic review and meta-analysis

enthalten in: Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences | 2022

von Lim, P. | Wong, K. | Rajah, R. | +4

7

Comparing efficacy and safety of tocilizumab and methylprednisolone in the treatment of patients with severe COVID-19

enthalten in: International immunopharmacology | 2022

von Abbasian, L. | Toroghi, N. | Rahmani, H. | +10

8

Secondary Infection Risk in Patients With Severe COVID-19 Pneumonia Treated With Tocilizumab

enthalten in: American journal of therapeutics | 2022

von Sandhu, G. | Piraino, S. | Piticaru, J.

9

Severity-Adjusted Dexamethasone Dosing and Tocilizumab Combination for Severe COVID-19

enthalten in: Yonsei medical journal | 2022

von Hong, J. | Ko, J. | Yang, J. | +15

10

C-reactive protein cut-off for early tocilizumab and dexamethasone prescription in hospitalized patients with COVID-19

enthalten in: Scientific reports | 2022

von Camon, A. | Alonso, R. | Muñoz, F. | +120

1
2
3
4
5
Nächster »
[5]